New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
Pharmacodynamic effects in the human brain and energy metabolism biomarker data presented at AAIC support further clinical development of VNA-318 in Alzheimer’s disease LAUSANNE, Switzerland, July…
Read the full articleYou might also wanna read
ProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026
PMN310 demonstrated dose-dependent reduction of amyloid-beta oligomers in human cerebrospinal fluid following a single dose in healthy volun
An Experimental Alzheimer’s Drug Shows Promise Targeting a Different Brain Protein, New Study Shows
6PPD-Quinone aus Autoreifen: KI-Studie verknüpft Umweltgift mit Alzheimer-Risiko
CHONGQING / CHENGDU / LONDON (IT BOLTWISE) – Eine neue Analyse verknüpft 6PPD-Quinone, einen Abbau- und Reaktionsstoff aus Autoreifen, mit m
Reifenabrieb und Alzheimer: Studie findet beunruhigenden Zusammenhang
Reifenabrieb auf der Straße könnte das Gehirn schädigen: Eine neue Studie verknüpft die Chemikalie 6PPD-Chinon mit zentralen Alzheimer-Mecha
Neurociencias UMH descubre la clave biológica que hace a las mujeres más vulnerables al alzhéimer
Los resultados abren nuevas perspectivas para el desarrollo de futuras estrategias terapéuticas
Neurociencias UMH descubre la clave biológica que hace a las mujeres más vulnerables al alzhéimer
Los resultados abren nuevas perspectivas para el desarrollo de futuras estrategias terapéuticas
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Conditions : Dementia, Alzheimer's Type; Alzheimer's Disease Interventions : Drug: SAR448851; Drug: Placebo Sponsors : Sanofi Not yet recrui
Comments
Sign in to join the conversation.
No comments yet. Be the first.